Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Regeneration of Posterior Cruciate Ligament Injury Using Hypoxia Conditioned Allogenic Adipose Mesenchymal Stem Cell (AdMSC) and Ligament Derived Condition Medium (Secretome)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04889963
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:10.741143+00:00
Published At
2021-05-17T00:00:00+00:00
Record Updated At
2021-05-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Adypose Mesenchimal Stem Cell", "Ligament Rupture", "Ligament Derived Conditined Medium"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-05-17"
protocolSection.identificationModule.nctId
"NCT04889963"
protocolSection.identificationModule.officialTitle
"Regeneration of Posterior Cruciate Ligament Injury Using Hypoxia Conditioned Allogenic Adipose Mesenchymal Stem Cell (AdMSC) and Ligament Derived Condition Medium (Secretome)"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Adypose Mesenchimal Stem Cell (protocolSection.conditionsModule.conditions)
  • Ligament Rupture (protocolSection.conditionsModule.conditions)
  • Ligament Derived Conditined Medium (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.